Autonomic Dysfunction: A Driving Force for Myocardial Fibrosis in Young Duchenne Muscular Dystrophy Patients?

被引:0
作者
Tamara O. Thomas
John L. Jefferies
Angela Lorts
Jeffrey B. Anderson
Zhiqian Gao
D. Woodrow Benson
Kan N. Hor
Linda H. Cripe
Elaine M. Urbina
机构
[1] Cincinnati Children’s Hospital Medical Center,The Heart Institute
[2] Children’s Hospital of Wisconsin,Department of Pediatrics
[3] Nationwide Children’s Hospital,Department of Pediatrics
来源
Pediatric Cardiology | 2015年 / 36卷
关键词
Duchenne; Cardiomyopathy; Myocardial fibrosis; Heart rate variability; Tachycardia;
D O I
暂无
中图分类号
学科分类号
摘要
Cardiac manifestations of Duchenne muscular dystrophy (DMD) include progressive cardiac dysfunction and an elevated resting heart rate (HR). We hypothesized this elevated HR reflects autonomic dysfunction that can be identified by heart rate variability (HRV) analyses which will be associated with myocardial fibrosis by cardiac magnetic resonance imaging (cMR). DMD patients (N = 74) and controls (N = 17) had time and frequency domain HRV analyses calculated via Holter monitoring. Cardiac magnetic resonance imaging was performed on DMD cases only. χ2 test, T test, ANOVA, and logistic regression were used to perform comparisons between groups. A p value of <0.05 was used for statistical significance. DMD cases had higher resting average HR than controls (99.4 ± 8.9, 85.4 + 6.2, p < 0.001). Among HRV variables, decreases were seen in the following: standard deviation of R to R intervals, the percent RR intervals differing by >50 ms from previous RR interval, the root-meansquare of successive differences of RR intervals, the standard deviation of the mean R to R segment (SDANN), low frequency, and high frequency domain, all p values 0.001. Maximum HR and SDANN most significantly associated with positive LGE on cMR (p = 0.008, p = 0.016). DMD cases on beta blocker had an average HR lower than those not on beta blocker (p = 0.009), but with no difference in HRV analysis. DMD patients have reduced HRV and therefore autonomic dysfunction prior to the onset of heart failure which is associated with myocardial fibrosis.
引用
收藏
页码:561 / 568
页数:7
相关论文
共 144 条
[1]  
Bigger JT(1992)Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction Am J Cardiol 69 891-898
[2]  
Fleiss JL(1992)Frequency domain measures of heart period variability and mortality after myocardial infarction Circulation 85 164-171
[3]  
Steinman RC(1996)Skeletal, cardiac, and smooth muscle failure in duchenne muscular dystrophy Pediatr Neurol 14 7-12
[4]  
Rolnitzky LM(2001)Prognostic value of heart rate variability in time domain analysis in congestive heart failure J Interv Cardiac Electrophysiol 5 181-187
[5]  
Kleiger RE(1978)Sequence of cardiac changes in duchenne muscular dystrophy Am Heart J 95 283-294
[6]  
Rottman JN(2009)Circumferential strain analysis identifies strata of cardiomyopathy in duchenne muscular dystrophy: a cardiac magnetic resonance tagging study J Am Coll Cardiol 53 1204-1210
[7]  
Bigger JT(2009)Autonomic function in patients with duchenne muscular dystrophy Pediatr Int 51 33-40
[8]  
Fleiss JL(2005)Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy Circulation 112 2799-2804
[9]  
Steinman RC(2011)Pathophysiology and therapy of cardiac dysfunction in Duchenne muscular dystrophy Am J Cardiovasc Drugs 11 287-294
[10]  
Rolnitzky LM(1998)Prognostic role of heart rate variability in patients with a recent acute myocardial infarction Am J Cardiol 82 1323-1328